CIK 0000944695 · Large accelerated filer
HANOVER INSURANCE GROUP, INC.
Sign in to watch- Ticker
- THG
- Exchange
- NYSE
- Industry
- Fire, Marine & Casualty Insurance
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043263626
- Phone
- 5088551000
- Business address
- 440 LINCOLN ST, WORCESTER, MA, 01653
- Former names
- ALLMERICA FINANCIAL CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,989,003
- in 3 filings, $1.9M under 10b5-1 plans
Net −$7,989,003. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Kerrigan Dennis Francis Executive Vice President | Option exercise · Common Stock Option (right to buy) | −6,262 | 0 | ||
| 2026-05-20 | Roche John C President and CEO | Sale 10b5-1 | −3,152 | $193.21 | $609K | 146,216.75 |
| 2026-05-20 | Roche John C President and CEO | Sale 10b5-1 | −5,145 | $194.05 | $998K | 141,071.75 |
| 2026-05-20 | Roche John C President and CEO | Sale 10b5-1 | −61 | $194.77 | $12K | 141,010.75 |
| 2026-05-19 | Roche John C President and CEO | Option exercise 10b5-1 | +9,098 | $85.87 | $781K | 150,108.75 |
| 2026-05-19 | Roche John C President and CEO | Option exercise 10b5-1 | +24,026 | $104.11 | $2.5M | 174,134.75 |
| 2026-05-19 | Roche John C President and CEO | Shares withheld for taxes 10b5-1 | −24,766 | $193.79 | $4.8M | 149,368.75 |
| 2026-05-19 | Roche John C President and CEO | Option exercise · Common Stock Option (right to buy) 10b5-1 | −9,098 | 0 | ||
| 2026-05-19 | Roche John C President and CEO | Option exercise · Common Stock Option (right to buy) 10b5-1 | −24,026 | 48,052 | ||
| 2026-05-18 | Roche John C President and CEO | Sale 10b5-1 | −375 | $196.55 | $74K | 145,886.75 |
| 2026-05-18 | Roche John C President and CEO | Sale 10b5-1 | −2,260 | $197.61 | $447K | 143,626.75 |
| 2026-05-18 | Roche John C President and CEO | Sale 10b5-1 | −2,516 | $198.65 | $500K | 141,110.75 |
| 2026-05-18 | Roche John C President and CEO | Sale 10b5-1 | −100 | $199.23 | $20K | 141,010.75 |
| 2026-05-15 | Roche John C President and CEO | Option exercise 10b5-1 | +18,194 | $85.87 | $1.6M | 159,204.75 |
| 2026-05-15 | Roche John C President and CEO | Shares withheld for taxes 10b5-1 | −12,943 | $194.64 | $2.5M | 146,261.75 |
| 2026-05-15 | Roche John C President and CEO | Option exercise · Common Stock Option (right to buy) 10b5-1 | −18,194 | 9,098 | ||
| 2026-05-14 | Lowsley Denise Executive Vice President | Option exercise | +4,175 | $115.35 | $482K | 8,057.51 |
| 2026-05-14 | Lowsley Denise Executive Vice President | Sale | −4,175 | $191.73 | $800K | 3,882.51 |
| 2026-05-14 | Lowsley Denise Executive Vice President | Option exercise · Common Stock Option (right to buy) | −4,175 | 0 | ||
| 2026-05-12 | Donnell William E. Director | Grant or award | +843 | 843 |
Page 5 of 10 · 184 trades